Literature DB >> 2920011

Effect of heparin on the glia-derived-nexin-thrombin interaction.

A Wallace1, G Rovelli, J Hofsteenge, S R Stone.   

Abstract

In order to determine the specificity of the interaction between thrombin and glia-derived nexin (GdN), the inactivation of proteolytically modified human thrombin species by GdN has been studied. The second-order rate constants for the inactivation of alpha-, beta T-, gamma T- and epsilon-thrombin by GdN were 1.41, 0.63, 0.33 and 1.91 microM-1.s-1 respectively. The kinetic properties of gdN were also investigated in the presence of different types of heparin, fractionated according to antithrombin III-binding affinity. Association rate constants of both gdN and antithrombin III with alpha-thrombin were obtained using unfractionated, low- and high-affinity heparin types. The different heparin types gave optimal rates of inhibition at similar heparin concentrations for both inhibitors. At optimal heparin concentrations, the rate of inactivation of alpha-thrombin by GdN was 0.5-1.2 nM-1.s-1, which suggests that, under these conditions, the interaction is diffusion-controlled.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2920011      PMCID: PMC1135555          DOI: 10.1042/bj2570191

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

2.  Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.

Authors:  M Höök; I Björk; J Hopwood; U Lindahl
Journal:  FEBS Lett       Date:  1976-07-01       Impact factor: 4.124

3.  The role of heparin in the thrombin-antithrombin III reaction.

Authors:  E H Li; J W Fenton; R D Feinman
Journal:  Arch Biochem Biophys       Date:  1976-07       Impact factor: 4.013

4.  Glia-induced morphological differentiation in neuroblastoma cells.

Authors:  D Monard; F Solomon; M Rentsch; R Gysin
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

5.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

6.  Evidence for a heparin-induced conformational change on antithrombin III.

Authors:  G B Villaneuva; I Danishefsky
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

7.  Binding of low-affinity and high-affinity heparin to antithrombin. Ultraviolet difference spectroscopy and circular dichroism studies.

Authors:  B Nordenman; I Björk
Journal:  Biochemistry       Date:  1978-08-08       Impact factor: 3.162

8.  The size and shape of human and bovine antithrombin III.

Authors:  B Nordenman; C Nyström; I Björk
Journal:  Eur J Biochem       Date:  1977-08-15

9.  A catalytic role for heparin. Evidence for a ternary complex of heparin cofactor thrombin and heparin.

Authors:  M W Pomerantz; W G Owen
Journal:  Biochim Biophys Acta       Date:  1978-07-21

10.  Preparation and characterization of proteolyzed forms of human alpha-thrombin.

Authors:  P J Braun; J Hofsteenge; J Y Chang; S R Stone
Journal:  Thromb Res       Date:  1988-04-15       Impact factor: 3.944

View more
  5 in total

1.  Interaction of activated protein C with serpins.

Authors:  J M Hermans; S R Stone
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

2.  In vitro and in vivo antiangiogenic properties of the serpin protease nexin-1.

Authors:  Sonia Selbonne; Feriel Azibani; Soria Iatmanen; Yacine Boulaftali; Benjamin Richard; Martine Jandrot-Perrus; Marie-Christine Bouton; Véronique Arocas
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

3.  Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.

Authors:  A D Snow; H Mar; D Nochlin; R T Sekiguchi; K Kimata; Y Koike; T N Wight
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

4.  The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.

Authors:  W Bode; D Turk; A Karshikov
Journal:  Protein Sci       Date:  1992-04       Impact factor: 6.725

5.  Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.

Authors:  A van de Locht; D Lamba; M Bauer; R Huber; T Friedrich; B Kröger; W Höffken; W Bode
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.